Ignite Creation Date:
2025-12-25 @ 12:44 AM
Ignite Modification Date:
2026-02-25 @ 8:11 PM
Study NCT ID:
NCT02010567
Status:
TERMINATED
Last Update Posted:
2020-11-03
First Post:
2013-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12
Start Date Type:
None
Primary Completion Date:
2016-09-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-25
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-09
First Submit QC Date:
None
Study First Post Date:
2013-12-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-10-13
Results First Submit QC Date:
None
Results First Post Date:
2017-11-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-15
Last Update Post Date:
2020-11-03
Last Update Post Date Type:
ACTUAL